To examine whether microwaves would protect the activity of catalase in blood against the toxicity of cyclophosphamide (CPA), a commonly used anticancer drug.
Animals were irradiated before and after the administration of CPA.
Exposure | Parameters |
---|---|
Exposure 1:
42.2 GHz
Modulation type:
CW
Exposure duration:
30 min/d, 5 d/week for 3 weeks
|
|
Modulation type | CW |
---|
Exposure source |
|
---|---|
Setup | Animals restrained in cylindrical tubes (3.5 cm) in such a way that the midback was located under the Petri dish. |
Additional info | A 35 mm hole was cut on one side of the tube and a 35 mm petri dish was welded on the hole. A plastic ring around the horn was kept in contact with the Petri dish during exposure. |
Measurand | Value | Type | Method | Mass | Remarks |
---|---|---|---|---|---|
SAR | 622 mW/g | peak value | cf. remarks | cf. remarks | +/- 100 W/kg |
power density | 310 W/m² | mean | measured | - | +/- 5 mW/cm² |
Millimeter waves at 42.2 GHz and at the power levels commonly used in cancer therapy, before and after administration of CPA did not reduce the toxic effect of CPA on catalase activity in blood of mice.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.